Eye tracking and cognition in multiple sclerosis
Part of Brain & nervous system, Eyes & vision, Immune system & allergy, Mental health clinical trials.
This study uses an eye-tracking camera and simple cognitive tests to look for early signs of thinking or memory problems in people with multiple sclerosis (MS). It may help find these issues sooner so they can be managed better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed MS diagnosis based on the 2017 McDonald criteria.
- You must be 18 years or older.
- Your corrected vision (with glasses or contacts) must be good enough — better than 0.6 on the Snellen test.
- You must not have other major medical or psychiatric conditions that affect thinking.
- You must not have had a recent MS relapse (within the last 3 months) and must not have started or changed your MS treatment in the last 3 months.
- You must be willing to provide informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how well new eye-tracking software can measure eye movements in people with multiple sclerosis. It may help researchers track changes in how the nervous system works using a simple camera-based eye test.
This study uses advanced eye imaging (OCTA) and visual field testing to look at how multiple sclerosis affects the retina and optic nerve. The goal is to better understand the disease and potentially help track it.
This study tests how fast and how accurately your eyes process visual information and how eye movements look in people with multiple sclerosis. It may help researchers understand vision-related effects of MS using objective eye measurements.
This study uses advanced eye scans (OCT and retinal vessel imaging) to look for patterns in the retina that might be different in people with Multiple Sclerosis and other neuroinflammatory diseases. The goal is to find markers that could help doctors better understand and monitor these conditions.
This study looks back at medical records to learn more about internuclear ophthalmoplegia — an eye movement problem — especially in people with multiple sclerosis. By reviewing what happened to patients, researchers hope to understand the condition better and improve future care.
This trial uses brain MRI and eye imaging tests to study research markers in people with multiple sclerosis (MS) and related neurologic conditions. It may help researchers better understand these diseases and how they change over time.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.